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Abstract
All gamma-herpesviruses encode at least one homolog of the cellular enzyme formyl-glycineamide-phosphoribosyl-
amidotransferase. Murid herpesvirus-4 (MuHV-4) encodes 3 (ORFs 75a, 75b and 75c), suggesting that at least some copies
have acquired new functions. Here we show that the corresponding proteins are all present in virions and localize to
infected cell nuclei. Despite these common features, ORFs 75a and 75b did not substitute functionally for a lack of ORF75c,
as ORF75c virus knockouts were severely impaired for lytic replication in vitro and for host colonization in vivo. They showed
2 defects: incoming capsids failed to migrate to the nuclear margin following membrane fusion, and genomes that did
reach the nucleus failed to initiate normal gene expression. The latter defect was associated with a failure of in-coming
virions to disassemble PML bodies. The capsid transport deficit seemed to be functionally more important, since ORF75c
2
MuHV-4 infected both PML
+ and PML
2 cells poorly. The original host enzyme has therefore evolved into a set of distinct and
multi-functional viral tegument proteins. One important function is moving incoming capsids to the nuclear margin for viral
genome delivery.
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Introduction
Enzymes of DNA metabolism feature prominently among the
host genes captured by herpesviruses. An increased capacity for
nucleoside processing presumably once conferred on the capturing
virus a selective advantage. However, evolutionary pressures
change, for example as additional genes are acquired, allowing
established protein folds to be put to other uses. For example, the
cytomegalovirus ribonucleotide reductase homolog no longer
functions as such [1] and host dCTPase homologs captured by
gamma-herpesviruses are no longer dCTPases [2]. Thus, DNA
sequence comparisons of herpesvirus genes can tell us about the
past, but are not always informative about the present.
All sequenced gamma-herpesviruses share a homolog of the
cellular formyl-glycineamide-phosphoribosyl-amidotransferase
(FGARAT or FGAM synthase), which catalyzes the fourth of
ten steps in de novo purine biosynthesis [3]. The viral homologs are
more closely related to each-other than any is to the cellular gene,
implying a single capture event early in gamma-herpesvirus
evolution. Whether the captured gene has retained FGARAT
activity is unknown. An interesting feature of rhadinovirus
FGARATs is frequent gene duplication. For example, Bovine
Herpesvirus-4 [4] and Ovine Herpesvirus-2 [5] both have 2
copies, and Murid Herpesvirus-4 (MuHV-4) has 3: ORFs 75a, 75b
and 75c [6]. Analysis of Epstein-Barr virus lacking its (single)
ORF75 homolog, BNRF1, found no defect in DNA replication
after reactivation, but a 20-fold reduction in B cell transformation
by the progeny virions [7]. Electron microscopy and antigen
presentation assays suggested that these virions still reached
endosomes. Thus, rather than functioning in viral DNA
replication, BNRF1 appeared to function late in virion entry.
One approach to defining viral gene functions has been
genome-wide screening. A preliminary analysis of MuHV-4
random insertion mutants [8] identified ORF75c but not ORFs
75a or 75b as essential for in vitro lytic replication. These data
supported the idea of functional divergence. However, what these
functions might be was not addressed. Analyzing MuHV-4 lytic
transcripts by microarray hybridization [9–11] has been of limited
use for ORFs 75a/b/c, because latency associated ORF73
mRNAs splice across them [12]. ORF-specific microarray probes
consequently fail to distinguish dedicated ORF75a/b/c mRNAs
from incompletely spliced ORF73 mRNAs. This may be why
ORF50 over-expression, which down-regulates ORF73 transcrip-
tion, also appears to down-regulate ORFs 75a/b/c [13].
A mass spectrometry-based analysis of MuHV-4 virions [14]
identified ORF75c but not 75a or 75b. In looking for
glycosaminoglycan binding, we immunoprecipitated both
ORF75c and ORF75b from virions with heparin agarose [15].
The significance of this heparin binding is unclear, but the
recovery of ORF75b and ORF75c argued that both are virion
proteins. The KSHV ORF75 and EBV BNRF1 have also been
found in virions [16,17]. These data again suggest that the
FGAGRAT homologs have acquired other functions, as promot-
ing DNA replication is classically a function of herpesvirus early
gene products rather than the virion tegument.
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distribution of viral FGARAT homologs in infected cells remain
unknown. Here we have analyzed the MuHV-4 ORFs 75a, 75b
and 75c using monoclonal antibodies. We find that all 3 proteins
are present in virions and that at least ORFs 75b and 75c
accumulate in the nucleus after membrane fusion, even when new
protein synthesis is blocked. None of the FGARAT homologs
appeared to retain significant FGARAT activity. We show further
that ORF75c-deficient MuHV-4 remains capable of lytic
replication, although it was severely attenuated relative to the
wild-type. This reflected mainly a defect in capsid transport from
the site of membrane fusion in late endosomes to the nuclear
margin. ORF75c also disassembled PML bodies after viral entry.
Thus, the original host enzyme has evolved into a set of
functionally distinct virion tegument proteins.
Materials and Methods
Mice
Female C57BL/6 mice were purchased from Harlan U.K. Ltd.
(Bicester, U.K.), housed in the Cambridge University Department
of Pathology, and infected intranasally with MuHV-4 when 6–8
weeks old. Animal welfare conformed to the UK Animal Health
Act of 1981 (Home Office Project Licence 80/1992).
Cell lines
BHK-21 fibroblasts, 293T cells, HeLa cells, human foreskin
fibroblasts stably transfected with a PML-specific or a control
siRNA [18], CHO cells and the FGARAT-deficient mutant
CHO-AdeB [19], NIH-3T3-fibroblasts and the cre recombinase-
expressing derivative 3T3-CRE [20] were grown in Dulbecco’s
modified Eagle medium (Invitrogen, Paisley, U.K.) supplemented
with 2 mM glutamine, 100 U/ml penicillin, 100 mg/ml strepto-
mycin and 10% fetal calf serum (PAA laboratories, Linz, Austria).
To select FGARAT
+ cells, the fetal calf serum was dialyzed
extensively to remove free purines and the medium was
supplemented with 100 mM hypoxanthine (Sigma-Aldrich, Poole,
U.K.). Cells were transfected where indicated using Fugene-6
(Roche Diagnostics, Ltd., Lewes, U.K.).
Plasmids and viral mutagenesis
ORFs 75a (genomic co-ordinates 117904-114029 of Genbank
accession number U97553), 75b (113901-110074) and 75c
(109999-106067) [7] were amplified by PCR (Phusion DNA
polymerase, New England Biolabs, Hitchin, U.K.) using primers
that added a 59 MfeI site and a 39 SalI site to each coding sequence.
The PCR products were cloned into the EcoRI/XhoI sites of
pcDNA3 (Invitrogen). To disrupt ORF75c, a BamHI genomic
clone spanning genomic co-ordinates 107477-111869 [21] was
digested with HpaI (109078) and dephosphorylated with Antarctic
alkaline phosphatase (New England Biolabs). A self-complemen-
tary oligonucleotide encoding multiple stop codons, 59-CTAGC-
TAGCTAGAATTCTAGCTAGCTAG-39, was annealed, phos-
phorylated with polynucleotide kinase (New England Biolabs) and
ligated into the HpaI site. The mutated genomic clone was then
sub-cloned as a BamHI-digested fragment into the BamHI
restriction site of the pST76K-SR shuttle vector, and recombined
into the MuHV-4 BAC (strain MHV-68) by transient RecA
expression [22]. Three independent mutants were isolated
(75c
2.4, 75c
2.7, 75c
2.9) plus revertants of 75c
2.4 (revertant.1)
and 75c
2.7 (revertant.2) in which the wild-type genomic sequence
was recombined into the BAC in place of the inserted
oligonucleotide. ORF50
2 MuHV-4, in which genomic co-
ordinates 69177-67792 are replaced by the luciferase coding
sequence, was kindly provided by Dr. Stacey Efstathiou (Division
of Virology) and propagated in NIH-3T3 cells with tetracycline-
inducible ORF50 expression. This mutant will be described in
detail elsewhere. Infectious virus was reconstituted by transfecting
BAC DNA into BHK-21 cells. The loxP-flanked BAC/eGFP
cassette was removed where indicated by virus passage through
3T3-CRE cells. Virus stocks were then grown in BHK-21 cells
[23], passaging the cells as required until most showed cytopathic
effects. This was typically 4–5 days post inoculation with 0.001
p.f.u./cell for ORF75c
+ viruses and approximately 2 weeks post-
inoculation for ORF75c
2 viruses. Cell debris was pelleted by low-
speed centrifugation (10006g, 3 min) and discarded. Virions were
then recovered from supernatants by high speed centrifugation
(38,0006g, 90 min) and stored at 270uC.
Virus titrations
Infectious virus was titered by plaque assay on BHK-21 cells [24].
10-fold virus dilutions were incubated on cell monolayers (2 h,
37uC), then overlaid with 0.3% carboxymethylcellulose. The
monolayers were fixed in 4% formaldehyde 4 days later and stained
with 0.1% toluidine blue. We also assayed the infectivity of viruses
retaining the loxP-flanked BAC cassette by eGFP expression from its
HCMV IE1 promoter. Cells were exposed to 10-fold virus dilutions
(18 h, 37uC), then trypsinized, washed and analyzed for eGFP
expression by flow cytometry. The genome content of virus stocks
was quantitated by real-time PCR (Rotor-Gene, Corbett Research)
of the MuHV-4 M2 gene (forward primer genomic co-ordinates
4166-4188, reverse primer 4252-4228, Taqman probe 4219-4189).
The viral genome content of ex vivo tissue samples was analyzed
similarly, with adenosine phosphoribosyl transferase (APRT) [25]
amplified in parallel as a cellular control (forward primer
GGGGCAAAACCAAAAAAGGA, reverse primer GCTGGAAT-
TACCGCGGCT,probeCGCAAATTACCCACTCCCGACCC).
Viral transcript analysis
RNA was recovered from MuHV-4-infected cells and reverse
transcribed (MessageSensor RT kit, Ambion, Warrington, U.K.)
with a 39 gene-specific primer, followed by real-time PCR with the
same primer plus a 59 partner. PCR products were quantitated with
a gene-specific probe. We analyzed ORF73 (forward primer
genomic co-ordinates 104047-104063, reverse primer 104173-
104153, probe 104079-104104), ORF50 (forward primer genomic
co-ordinates 66779-66795/67661-67664 spanning ORF50 exon1/
exon2, reverse primer 67775-67756, probe 67698-67670) and the
cellular 18S rRNA as a control (forward primer CGGCTACCA-
CATCCAAGGAA, reverse primer TGTGTGTGGGGCCTGA-
GTC, probe TGCCTAAACACAAGCATCCCTACCTCAA).
PCR primers and HPLC-purified Taqman probes were manufac-
tured by TIB-Molbiol (Berlin, Germany). A standard curve for each
primer set was generated by parallel amplifications of plasmid
template dilutions, and the average copy number of triplicate PCR
reactions for each sample calculated from this.
Southern blotting
Viral DNA was extracted from virus stocks by alkaline lysis [24],
digested with EcoRI, electrophoresed through 0.8% agarose in Tris
acetate buffer and transferred to positively charged nylon mem-
branes (Roche Diagnostics). A
32P-dCTP labelled probe (APBiotech,
Little Chalfont, U.K.) was generated by random primer extension
(Nonaprimer kit, Qbiogene, Bingham, U.K.) of the BamHI-H
genomic clone (genomic co-ordinates 107477-111869) [21]. The
membranes were hybridised with the probe (65uC, 18 h), washed in
30 mM sodium chloride/3 mM sodium citrate/0.1% sodium
dodecyl sulfate at 65uC, and exposed to X-ray film. Circular and
MuHV-4 ORF75
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Virus-infected cells (2 p.f.u./cell, 18 h) were resuspended in 15%
Ficoll/100 mg/ml RNAase A and 10
6 cells/lane loaded into a
vertical agarose gel. The cells were then overlaid with an equal
volume of 5% Ficoll/1% SDS/100 mg/ml proteinase K and
electrophoresed to resolve linear and circular viral genomes. The
DNAwastransferred tonylonmembranesasaboveand probed with
a
32P-dCTP labelled probe corresponding to a 1.2 kb PstI-restricted
fragment [21] from the MuHV-4 terminal repeats.
Monoclonal antibodies (mAbs)
All mAbs were derived from MuHV-4-infected BALB/c mice
by fusing spleen cells with NS0 myeloma cells [27]. MAbs specific
for ORF75a (BN-3H8), ORF75b (CS-4A1) and ORF75c (BN-
6C12) are described in the results section. MAbs T3B8 (gp70,
IgG1) [15], T2C12 (gH/gL, IgG2a) [28], MG-4D11 (gB, IgG2a)
[29], MG-12B8 (ORF65 capsid component, IgG2a) [29], 3F7 (gN,
IgG2a) [30], CS-4A5 (thymidine kinase) [31] and 150-7D1
(ORF17 capsid component, IgG2a) [29] have been described.
MAb BH-6D3 (ORF25 capsid component, IgG1) was identified as
such by mass spectrometry of a 160 kDa protein it precipitated
from MuHV-4 virion lysates (Fig.S1).
Immunofluorescence and confocal microscopy
Adherentcells(BHK-21,293T orNIH-3T3)werewashedinPBS,
fixed in 4% paraformaldehyde (15 min), then permeabilized with
0.1% Triton-X100 (30 min) and blocked with 10% fetal bovine
serum in PBS (60 min). MuHV-4 virion components were detected
with mAbs (see above) plus Alexa488- or Alexa568-labeled anti-
mouse IgG (Invitrogen, Paisley, U.K.) or Alexa488- or Alexa633-
labeled anti-mouse IgG1 plus Alexa488- or Alexa568- labeled anti-
mouse IgG2a. EGFP fluorescence was visualized directly. PML was
detectedwith mAb PG-M3 (IgG1) (Santa Cruz Biotechnology,Santa
Cruz). The cells were washed62i nP B S / 0 . 1 %T w e e n - 2 0a f t e re a c h
antibody incubation and mounted in ProLong Gold anti-fade
reagent with DAPI (Invitrogen). Fluorescence was visualized with an
Olympus IX70 microscope plus a Retiga 2000R camera line
(QImaging) or with a Leica SP2 confocal microscope.
Metabolic labelling and immunoprecipitation
BHK-21 cells were infected with MuHV-4 (6 h, 37uC, 3 p.f.u./
cell) then washed 62 in PBS, and labelled for 2 h in cysteine/
methionine-free medium with dialysed fetal calf serum plus
35S-
labelled cysteine-methionine [32], followed by a further 40 h in
the same medium plus 3% non-dialyzed fetal calf serum. Cell
debris was pelleted (10006g, 10 min) and virions recovered from
the cleared supernatants by ultracentrifugation (20,0006g, 2 h).
Each fraction was lysed (30 min, 4uC) in 1% Triton X-100,
50 mM TrisCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM
PMSF, plus Complete protease inhibitors (Roche Diagnostics).
Insoluble debris was removed by centrifugation (13,0006g,
15 min). The supernatants were precleared with normal rabbit
serum plus protein A/protein G-sepharose. Thymidine kinase,
ORF75a and ORF75c were then immunoprecipitated with
specific mAbs followed by protein A/protein G-sepharose. The
sepharose beads were washed 65 in lysis buffer. The precipitated
proteins were then eluted and denatured by heating (95uC, 5 min)
in Laemmli’s buffer and resolved by SDS-PAGE. Dried gels were
exposed to X-ray film.
Immunoblotting
Virions were lysed and denatured by heating (95uC, 5 min) in
Laemmli’s buffer. Virion proteins were resolved by SDS-PAGE,
transferred to PVDF membranes and probed with MuHV-4-specific
mAbs plus horseradish peroxidase-conjugated rabbit anti-mouse
IgG pAb (Dako Cytomation, Ely, U.K.), followed by ECL substrate
development (APBiotech) [33]. To visualize all proteins, gels were
stained with 0.15% Coomassie R-250 in 50% methanol/10% acetic
acid (30 min), then destained in the same buffer without dye (1 h)
and further in 5% methanol/7% acetic acid (18 h).
Flow cytometry
BHK-21 cells were left uninfected or exposed to BAC
+ ORF75
+
or ORF75
2 MuHV-4 (18 h, 37uC), then trypsinized, washed 62
in PBS and analyzed for viral eGFP expression by flow cytometry
using a FACSort (BD Biosciences, Oxford, U.K.).
Electron microscopy
BHK-21 cells were infected with wild-type MuHV-4 (1 p.f.u./
cell, 18 h) or with ORF75c
2.4 MuHV-4 to an equivalent level of
viral eGFP expression, then washed in 0.9% NaCl, fixed in 2%
Glutaraldehyde/0.3% H2O2 (2 h, 4uC), washed in 0.1 M HEPES
buffer pH=7.4, and stained and embedded for transmission
electron microscopy [24].
Results
Identification of the ORF 75a, 75b and 75c gene products
Our first aim was to derive antibodies capable of identifying the
ORF75a, ORF75b and ORF75c gene products. To this end, B
cell hybridomas were derived from MuHV-4-infected mice by
fusing their spleen cells with NS0 myeloma cells. Antibodies
specific for ORFs 75a, 75b or 75c were identified by using
hybridoma supernatants to stain 293T cells transfected with the
corresponding expression plasmids (Fig. 1A). Although none of the
viral FGARAT homologs has an obvious nuclear localization
signal, all localized to the nucleus after transfection.
We also stably expressed each FGARAT homolog in
FGARAT-deficient CHO-AdeB cells. These showed the same
nuclear localization of ORF75a/b/c (Fig. 1B). None of the viral
ORFs was able to rescue these cells for growth in purine-deficient
medium supplemented with hypoxanthine. Thus, both ORF75a/
b/c-transfected and untransfected CHO-AdeB cells (but not
normal CHO cells) underwent growth arrest in purine-deficient
medium. No clones grew out of the transfected populations, and
immunofluoresence established that 3 weeks of culture in purine-
deficient medium had failed to enrich for ORF75a/b/c expres-
sion. By this measure, therefore, none of the ORF75 homologs
retained significant FGARAT activity.
We next determined the distributions of ORF75a/b/c in
MuHV-4-infected cells (Fig. 1C). Again, all 3 proteins were
present in nuclei. The main difference from transfected cells was
additional cytoplasmic staining. Herpesvirus secondary envelop-
ment occurs in the trans-Golgi network, so tegument proteins
generally accumulate in the cytoplasm to await packaging into
virions [34]. The additional cytoplasmic ORF75a/b/c staining of
infected cells was therefore consistent with the ORF75a/b/c
proteins being packaged into virions.
ORFs 75a, 75b and 75c all encode virion proteins
We reasoned that if ORFs 75a/b/c were virion components
they would be delivered into newly infected cells, and might
therefore appear in the nuclei of these cells shortly after membrane
fusion, even without new protein synthesis. To test this, we
exposed BHK-21 cells to wild-type MuHV-4 virions for 4 h, with
or without concurrent cycloheximide treatment to block protein
synthesis, then stained the cells for ORFs 75a, 75b and 75c. The
MuHV-4 ORF75
PLoS ONE | www.plosone.org 3 July 2008 | Volume 3 | Issue 7 | e2781Figure 1. Immunostaining of ORFs 75a/b/c. A. 293T cells were transfected with a mammalian expression vector encoding ORF75a, ORF75b or
ORF75c. 48 h later the cells were fixed in 4% paraformaldehyde, permeabilized with Triton-X100 and stained with mAbs derived from MuHV-4-
infected mice. Positive staining is green. Nuclei were counter-stained with DAPI (blue). Each field shown is representative of at least 50 examined. B.
FGARAT-deficient CHO-AdeB cells were transfected with ORF75a/b/c expression constructs as in A, then selected for 2 weeks in G418 and switched to
purine-free medium with hypoxanthine for a further 3 weeks. This led to growth arrest. The cells were then switched back to normal medium and
ORF75a/b/c expression tested by immunostaining as in A. C. BHK-21 cells were infected with wild-type MuHV-4 (2 p.f.u./cell, 18 h), then fixed in 4%
paraformaldehyde, permeabilized with Triton-X100 and stained with ORF75a/b/c-specific mAbs. Nuclei were counterstained with DAPI. Only merged
images are shown for the uninfected controls.
doi:10.1371/journal.pone.0002781.g001
MuHV-4 ORF75
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component. As a further control, we treated some cells with
bafilomycin to block viral membrane fusion [28] and therefore
tegument protein delivery (Fig. 2A). Without drug treatment,
ORF65 staining showed incoming capsids accumulating around
the nuclear margin. As expected, this was dependent on
membrane fusion - the MG-12B8 epitope is inaccessible on intact
virions [28] - and independent of new protein synthesis. The few
capsid antigens visible with bafilomycin treatment did not show a
peri-nuclear localization and probably corresponded to damaged
virions or infected cell debris present in the virus stock.
Glycoprotein N (mAb 3F7) was accessible, and by its distribution
endocytosed regardless of drug treatment.
ORFs 75b and 75c both accumulated in the nuclei of cells
exposed to virions regardless of cycloheximide treatment. They
therefore appeared to be virion components rather than
immediate-early gene products. Neither was identifiable in the
nuclei of bafilomycin-treated cells. Instead, there was staining of
cytoplasmic inclusions in a similar pattern to gN. These data were
consistent with ORFs 75b and 75c being endocytosed as
components of virions, then homing to the nucleus when released
from the virion tegument by membrane fusion.
ORF75a nuclear staining was hard to discern in newly infected
cells, either because this antibody was less good for detection or
because MuHV-4 virions contain less ORF75a protein than
ORF75b or ORF75c. Fig. 2B makes clear that even exposure
times sufficient to show background staining of uninfected cells
failed to reveal convincing nuclear staining of infected cells. The
main additional staining of infected cells was in cytoplasmic
inclusions suggestive of endocytosed virions.
Because the detection of incoming ORF75a by immunofluo-
rescence was weak, we confirmed its presence in virions by
immunoprecipitation from virion lysates (Fig. 2C). MuHV-4-
infected BHK-21 cells were labelled with
35S-cysteine/methionine
from 6–48 h post-infection. Infected cell debris was then removed
by centrifugation, cell-free virions were recovered from the cleared
supernatants by ultracentrifugation, and ORF75a was immuno-
precipitated from each fraction. The known virion proteins
ORF75c and thymidine kinase (TK) were immunoprecipitated
in parallel as controls. ORF75a was clearly recoverable from both
virions and infected cells, much like ORF75c. A 70 kDa protein
co-precipitated, albeit weakly, with both ORF75a and ORF75c
from virions but not from infected cells. This protein was
equivalent in size to TK, and the TK-specific mAb reciprocally
co-precipitated a 150 kDa band from virions but not from infected
cells. These data were consistent with TK and ORF75a/ORF75c
associating in the virion tegument. The co-precipitation with TK
of a 45 kDa band from infected cells but not from virions pointed
to additional changes in protein association during virion
assembly. This was not pursued further. The main conclusion of
the immunoprecipitations was that ORF75a, like ORF75c, was
present in virions.
ORF75c-deficient MuHV-4 is replication-competent but
highly attenuated
In so far as ORFs 75a/b/c all encoded tegument proteins that
localized to the nuclei of infected cells, they appeared to be quite
similar. However, the viability of ORF75a and ORF75b but not
ORF75c mutants [8] indicated important functional differences.
As a first step in identifying what these functions might be, we
generated a virus lacking ORF75c. An oligonucleotide encoding
multiple stop codons was inserted close to the ORF75c N-terminus
(Fig. 3A). Restriction enzyme mapping of BAC DNA (data not
shown) and Southern blots of viral DNA (Fig. 3B) confirmed the
expected genome changes.
The propagation of ORF75c
2 mutants after BHK-21 cell
transfection with BAC DNA was noticeably worse than that of the
wild-type. ORF75c
+ viruses all spread rapidly, whereas several cell
passages were required before ORF75c
2 viral replication out-
stripped cell division. ORF75c
2 plaque formation was correspond-
inglypoor:the cellstendedtoover-growbeforeaplaquewasformed.
We therefore compared ORF75c
+ and ORF75c
2 virus stocks
primarily by viral genome content, using real-time PCR, and we
assayed infectivity by eGFP expression from a Human cytomega-
lovirus (HCMV) IE1 promoter in the BAC cassette rather than by
plaque formation. The genome:eGFP expression ratio was 10–100-
fold higher for ORF75c
2 mutants than the wild-type, depending on
the multiplicity of infection (Fig. 3C). Thus, it appeared that many
more ORF75c
2 particles were required to establish an infection.
We performed growth curves by measuring the %eGFP
+ cells
with time in BHK-21 cell populations exposed to BAC
+ viruses at
low multiplicity (Fig. 3D). This approach provided further
quantitation of the ORF75c
2 replication deficit. It also emphasized
that although ORF75c
2 mutants were attenuated, they remained
replication competent. This difference from transposon screening,
where ORF75c was identified as essential [8], presumably reflects
that genome-wide screens can miss details such as low efficiency
propagation. With single gene mutants, it is more feasible to alter in
vitro growth conditions, such as cell density, to take account of
attenuation. There was no sign that the ORF75c
2 viruses recovered
from in vitro growth curves replicated faster than the original inocula,
and they remained ORF75c
2 by immunofluorescence and by DNA
sequence across the mutation site (data not shown).
Normal ORF75c
2 virion morphogenesis
Since ORF75c appeared to be a component of the MuHV-4
tegument, a possible explanation for the replication deficit of
ORF75c knockouts was that they failed to assemble virions properly.
However, immunoblots established that in ORF75c
+ and ORF75c
2
virus stocks, equivalent genome numbers corresponded to roughly
equivalent amounts of virion capsid (ORF17), glycoprotein (gB) and
tegument(thymidinekinase)(Fig.4A).Theonlyobviousabnormality
on Coomassie staining of virion lysates (Fig. 4B) was a reduction in
the 150 kDa band that contains ORF75c (Fig. 2C), ORF75a
(Fig. 2C), ORF75b [15] and gp150 [15]. The visible reduction in
protein content by ORF75c disruption alone implied that ORF75c,
or a virion protein that requires it for packaging, is the major
component of this band. Finally, electron microscopy showed no
obvious morphological difference between ORF75c
+ and ORF75c
2
infected BHK-21 cells (Fig. 4C). In particular, we could readily
identify morphologically normal ORF75c
2 virions being released
from infected cells.
ORF75c
2 virions are deficient in establishing both lytic
and latent infections
Since electron microscopy showed no ORF75c-dependent
virion assembly defect, the limited viability of ORF75c
2 viruses
seemed likely to reflect a problem in establishing infection. Cell
binding and penetration depend primarily on virion glycoproteins,
but post-fusion events may depend on the tegument. One
possibility suggested by the nuclear localization of incoming
ORF75c (Fig. 3A) was that it might function as a lytic gene
transactivator like the Herpes simplex virus VP16 [35]. If so, we
would expect transcription of the lytic switch gene, ORF50, to be
reduced without ORF75c, and that of latency genes such as
ORF73 [12] to be relatively preserved. To test this, we exposed
cells to ORF75c
+ or ORF75c
2 virions, then quantitated ORF50
MuHV-4 ORF75
PLoS ONE | www.plosone.org 5 July 2008 | Volume 3 | Issue 7 | e2781Figure 2. Identification of ORFs 75a/b/c as virion components. A. BHK-21 cells were incubated with wild-type MuHV-4 virions (5 p.f.u./cell,
6h ,3 7 uC), with or without cycloheximide (100 mg/ml) to block new protein synthesis or bafilomycin (500 nM) to block virion membrane fusion. The
cells were then fixed in 4% paraformaldehyde, permeabilized with Triton X-100 and stained (green) for ORF75b, ORF75c, the ORF65 virion capsid
component or glycoprotein N (gN). Nuclei were counterstained with DAPI (blue). B. BHK-21 cells were exposed to MuHV-4 virions as in A without
drug treatment, then fixed, permeabilized and stained for ORF75a. At the exposure necessary to see strong positive staining, background staining of
uninfected controls was also evident. C.
35S-cysteine/methionine-labelled, MuHV-4-infected BHK-21 cultures were separated into infected cell and
virion fractions, lysed in Triton X-100 and precipitated with mAbs specific for thymidine kinase (TK), ORF75c (75c) or ORF75a (75a), plus protein A/
protein G-sepharose. Immunoprecipitated proteins were separated by SDS-PAGE and visualized by autoradiography. The predicted sizes of ORF75a
(142 kDa), ORF75c (146 kDa) and TK (72 kDa) are marked.
doi:10.1371/journal.pone.0002781.g002
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(Fig. 5A). When ORF75c was lacking, ORF73 transcripts were
reduced by at least as much as ORF50. Thus, the infection block
appeared to affect viral gene expression generally rather than just
in the lytic cycle. This result was consistent with ORF75c mutants
showing poor BAC cassette-based eGFP expression (Fig. 3C), since
the HCMV IE1 promoter driving eGFP expression operates quite
independently of endogenous MuHV-4 transcription [36,37]. We
also found no evidence that co-transfected ORF75c transactivates
the ORF50 promoter in CAT assays (data not shown).
Figure 3. Generation of ORF75c
2 MuHV-4 mutants. A. Schematic diagram of the ORF75c genomic locus and the introduced stop oligo
mutation. B. Southern blot of viral DNA recovered from wild-type (WT), ORF75c mutant (75c
2.4, 75c
2.7, 75c
2.9) and 75c
2.4 revertant (75c
+rev.1) virus
stocks. The viral DNA was digested with EcoRI and probed with the labelled BamHI-H genomic fragment shown in A. There is an invariant band of
5186 bp. The wild-type 7776 bp band shifts to 7048 bp in the mutant. The small mutant band of 728 bp is not visible on this gel. C. Two ORF75c
2
mutants were compared with wild-type and revertant viruses for infectivity. The viral genome content of each stock was determined by real-time
PCR, and equivalent genome numbers used to infected BHK-21 cells (18 h, 37uC). The number of infected cells was determined by flow cytometry of
eGFP expression from the MuHV-4 BAC cassette. D. BHK-21 cells were infected with ORF75c
2 (ORF75c
2.4, ORF75c
2.7) or ORF75c
+ (wild-type,
revertant.1) viruses at 10 genomes/cell - equivalent for the wild-type and revertant to 0.01 p.f.u./cell. The spread of infection with time was assayed by
flow cytometry of viral eGFP expression.
doi:10.1371/journal.pone.0002781.g003
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+ or ORF75c
2
virions (Fig. 5B) confirmed a lack of ORF75c
2 viral DNA
replication (Fig. 5A) - ORF75c
2 genomes could only be visualized
with long exposure times. A relatively high proportion of these
genomes appeared to be circular rather than linear. Since
herpesvirus genomes are linear when packaged into virions and
Figure 4. No evidence for ORF75c deficiency compromising virion morphogenesis. A. Wild-type (WT), ORF75c
2 (75c
2.4, 75c
2.7, 75c
2.9)
and revertant (rev.1, rev.2) virus stocks were normalized by genome content, denatured in Laemmli’s buffer and immunoblotted for the ORF17 capsid
component with mAb 150-7D1, for gB (C-terminal furin cleavage product) with mAb MG-4D11, and for thymidine kinase (TK) with mAb CS-4A5. B.
Virus stocks were denatured, resolved by SDS-PAGE and analyzed by Coomassie staining. The positions of bovine albumin (alb, 63 kDa), the ORF25
capsid component (160 kDa) and the ORFs 75a/b/c (150 kDa) are shown. C. BHK-21 cells were infected with wild-type (WT) MuHV-4 (1 p.f.u./cell,
18 h) or ORF75c
2.4 (ORF75c
2) MuHV-4 to an equivalent infection level based on viral eGFP expression, then processed for transmission electron
microscopy. The scale bars show 1 mM in the overview images. nuc=nucleus, cyt=cytoplasm. The boxed regions in the overview images correspond
to the zoomed images 1–4. The arrows show examples of mature virions.
doi:10.1371/journal.pone.0002781.g004
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2 MuHV-4 shows defective immediate early gene expression. A. BHK-21 cells were infected (1000 genomes/cell) with
wild-type (WT) or ORF75c
2.4 (ORF75c
2) virions. DNA and RNA were recovered at 6 h and 24 h post-infection. RNA was reverse transcribed using
ORF50, ORF73 and 18S rRNA-specific primers and cDNAs quantitated by real-time PCR. Controls without reverse transcriptase were all negative. Each
sample was run in triplicate and mean copy numbers determined by comparison with known template dilutions. Viral genome numbers were
quantitated by amplificating 100 ng DNA with MuHV-4 M2-specific primers and comparing with known template dilutions. B. BHK-21 cells were
infected with ORF75c
+ (WT, rev.1) or ORF75c
2 (75c
2.4, 75c
2.7, 75c
2.9) viruses (2 p.f.u./cell or an equivalent number of genomes), and 18 h later lysed
in situ in agarose gels. UI=uninfected cells. Circular and linear genomes were distinguished by electrophoretic mobility and comparison with circular
genomic BACs, which differ in size due to different numbers of terminal repeats. Viral genomes were identified by probing with a labelled terminal
repeat fragment. The boxed area was exposed for a longer time to visualize ORF75c
2 genomes. C. BHK-21 cells were infected with BAC
+ORF75c
2
MuHV-4 (1000 genomes/cell), then 24 h later super-infected with BAC
2ORF50
2 MuHV-4 (1000 genomes/cell), then 24 h later analyzed for BAC-based
eGFP expression by flow cytometry. Each bar shows 20,000 cells. The data are from 1 of 3 equivalent experiments. The increase in eGFP expression
with ORF50
2 superinfection was highly significant (p,10
26 by Chi-squared test).
doi:10.1371/journal.pone.0002781.g005
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genomes still reached the nucleus without ORF75c, but failed to
amplify the genome load by lytic replication. In conjunction with
the earlier transcription analysis (Fig. 5A), these data suggested
that ORF75c
2 infection was blocked between genome circular-
ization and the initiation of either lytic or latent transcription.
We tested whether the ORF75c
2 genomes in virus-exposed
cells might remain viable by super-infecting these cells 24 h later
with ORF50
2 virions (Fig. 5C). ORF50
2 mutants are non-viable
unless grown in a complementing cell line [39]. Thus in non-
complementing cells they deliver tegument proteins such as
ORF75c but do not initiate lytic infection. BHK-21 cells were
exposed to BAC
+ORF75c
2 virions then super-infected with
BAC
2ORF50
2 virions. There was significant ORF75c
2 genome
rescue as judged by BAC-based eGFP expression. Because the
ORF50
2 and ORF75c
2 genomes could potentially recombine
with complicated results, detailed analysis of the super-infections
was not attempted. But it seemed clear that some otherwise non-
functional ORF75c
2 genomes could be rescued by delivering an
ORF75c
+ virion tegument.
ORF75c destroys PML bodies, although this does not
explain the ORF75c
2 replication deficit
An infection block between genome circularization and viral
gene expression suggested that PML bodies (ND10 domains)
might be involved in the ORF75c
2 phenotype. PML bodies
constitute a major innate defence against incoming viral genomes,
and are a common target for immediate-early herpesvirus gene
products [40]. 4 h after exposure to wild-type MuHV-4 virions,
HeLa cells showed an almost complete loss of PML bodies
(Fig. 6A). This effect was not blocked by cycloheximide, consistent
with it being due to a virion component rather than an immediate-
early gene product. In contrast to wild-type infection, exposing
HeLa cells to ORF75c
2 virions made their PML bodies more
prominent. The increase in PML staining depended on new
protein synthesis, as it was blocked by cycloheximide, but even
with cycloheximide present ORF75c
2 virions caused no loss of
PML staining. Therefore ORF75c itself or a virion protein
functionally dependent on ORF75c disrupted the PML bodies of
newly infected cells.
Transfecting expression plasmids provided evidence that PML
body disruption is a direct action of ORF75c (Fig. 6B). PML
bodies were visible as discrete intra-nuclear dots in ORF75c-
negative cells, but were either redistributed to the nuclear margin
or not visible at all in 293T cells expressing ORF75c. We tested
whether a lack of PML disruption could explain the ORF75c
replication deficit by exposing PML-deficient cells to wild-type and
ORF75c
2 virions. A severe ORF75c-dependent block to viral
eGFP expression remained (Fig. 6C). Thus, although ORF75c
disassembled PML bodies, this action was insufficient to explain
the replication deficit of ORF75c
2 virions.
ORF75c
2 virion capsids show defective migration to the
nuclear margin
The relative increase in circular over linear ORF75c
2 genomes
on Gardella gels of infected cells (Fig. 5B) argued that some
ORF75c
2 genomes reaching the nucleus failed to initiate lytic
replication. However, it remained unclear what fraction of input
genomes reached the nucleus. For example, any still trapped in
capsids might not have been efficiently released by SDS/
proteinase K treatment. And although some input genomes could
be rescued by super-infection (Fig. 5C), the fraction of eGFP
+ cells
remained low even with an input of approximately 1000
ORF75c
2 genomes per cell, arguing that the rescue was
inefficient. Another block to infection therefore seemed likely.
To address where this might be, we examined by immunofluo-
rescence the distribution of capsid antigens in BHK-21 cells 6 h
after exposure to ORF75
+ or ORF75
2 virions (Fig. 7A). The
delivery of gH/gL was similar between viruses; ORF75b also
reached the nucleus regardless of ORF75c, consistent with normal
membrane fusion; but ORF75c
2 virions showed a major defect in
capsid transport to the nuclear margin. With the wild-type,
ORF25 and ORF65 capsid antigens were each clustered around
the nuclear margin. With the ORF75c
2.4 mutant, less capsid
staining was evident and it was scattered in the cytoplasm rather
than peri-nuclear.
The same was true of NIH-3T3 fibroblast and NMuMG
epithelial cell infections (Fig. 7B): incoming gB, gN and TK were
similarly distributed 6 h after exposure to ORF75c
+ or ORF75c
2
virions, but without ORF75c there was less capsid staining and
what staining there was was scattered in the cytoplasm rather than
concentrated around the nuclear margin. All the ORF75c mutants
showed the same phenotype, while revertant viruses were normal
(Fig. 7C). Imaging after 1 h (Fig. 7D) showed little difference in
ORF75c
+ versus ORF75c
2 capsid staining, but after 2 h there was
less accessible capsid antigen for the ORF75c
2 mutants, and after
6 h the distribution of capsid antigens was clearly different. Thus,
the capsids of ORF75c
2 virions failed to be properly revealed (or
were degraded) and failed to migrate to the nuclear margin.
ORF75c
2 mutants fail to establish a detectable infection
in vivo
A key question for any MuHV-4 molecular deficit is how it
manifests in vivo. We addressed this here by intranasal infection of
mice with ORF75c
2 and ORF75c
+ viruses (Fig. 8). Since the
former were hard to detect by plaque assay, we used real-time
PCR of viral genomes to measure host colonization (Fig. 8A).
Wild-type genome numbers increased from day 1 to day 3 post-
inoculation in the lung and were readily detectable at 30 days post-
inoculation in the spleen. ORF75c
2 genomes were also detectable
in the lung after intranasal infection, but failed to increase in
number, implying that we were probably detecting just the input
virus.
The severe in vivo lytic replication of MuHV-4 thymidine kinase
knockouts does not stop them colonizing the spleen by 30 days
post-inoculation [23]. However, viral genomes were only detect-
able in the spleen at very low levels 30 days after ORF75c
2
infection, close to the limit of assay sensitivity (Fig. 8A). There was
also no sign of ORF75c
2 viruses inducing virus-driven B cell
activation (Fig. 8B), Vb4
+CD8
+ T cell expansion (Fig. 8B) or virus-
specific serum IgG (Fig. 8C). A lack of ORF75c therefore caused a
severe defect in host colonization, with little evidence of either lytic
replication or normal latency establishment.
Discussion
DNA sequence alignments tell us the evolutionary histories of
viral genes but not necessarily their present functions, as similar
protein folds can be adapted to very different purposes.
Herpesvirus DNA replication enzymes are generally early gene
products, whereas ORFs 75a/b/c all encoded tegument proteins,
and none of these FGARAT homologues complemented
FGARAT-deficient cells. The functions of herpesvirus tegument
proteins in newly infected cells are not well defined. Lytic functions
such as DNA replication seem unlikely, as incoming genomes
often establish latency. Indeed, the transcriptional activation [35]
and host shutoff [41] functions of the Herpes simplex virus
MuHV-4 ORF75
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function in neurons. We identified two functions for ORF75c:
capsid transport to the nuclear margin and PML body disruption.
The dominant defect appeared to be capsid transport, since
ORF75c knockouts remained highly attenuated in PML-deficient
cells.
Most analyses of herpesvirus capsid transport have focussed on
Herpes simplex virus [42] and Pseudorabies virus [43], which
travel long distances in neurons during latency establishment and
reactivation. Tegument proteins are sequentially released, with the
inner tegument proteins presumably interacting with host motor
proteins [44]. But what these proteins are and how they function
Figure 6. ORF75c disrupts PML bodies. A. HeLa cells were left uninfected or infected with ORF75c
+ (wild-type, revertant.1) or ORF75c
2
(ORF75c
2.4, ORF75c
2.9) viruses (1000 genomes/cell), with or without 100 mg/ml cycloheximide to block new protein synthesis. 6 h later, the cells
were fixed, permeabilized and stained for gN (mAb 3F7, IgG2a, red) and PML (mAb PG-M3, IgG1, green). Nuclei were counterstained with DAPI (blue).
B. 293T cells were transfected with pcDNA3-ORF75c and 48 h later fixed, permeabilized and stained for ORF75c (mAb BN-6C12, IgG2a, red) and PML
(mAb PG-M3, IgG1, green). Nuclei were counterstained with DAPI (blue). Two independent transfections are shown. The arrows show ORF75c
+ cells.
C. Human foreskin fibroblasts made PML-deficient by siRNA expression or expressing a control siRNA were infected (1000 genomes/cell) with wild-
type or ORF75c
2.4 BAC
+ MuHV-4. Viral infection was assessed 18 h later by viral eGFP expression. D. A similar experiment to C, but with viral eGFP
expression quantitated by flow cytometry.
doi:10.1371/journal.pone.0002781.g006
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PLoS ONE | www.plosone.org 11 July 2008 | Volume 3 | Issue 7 | e2781Figure 7. ORF75c disruption impairs the transport of incoming capsids. A. BHK-21 cells were infected (1000 genomes/cell, 6 h) with wild-
type or ORF75c
2.4 MuHV-4, then stained (red) for ORF65 capsid component (mAb MG-12B8), ORF25 capsid component (mAb BH-6D3), gH/gL (mAb
T2C12), ORF75b (mAb CS-4A1) or ORF75c (mAb BN-6C12). Nuclei were counter stained with DAPI (blue). B. NIH-3T3 cells or NMuMG cells were
infected (1000 genomes/cell, 6 h) with wild-type or ORF75c
2.4 MuHV-4, then stained (red) for ORF65 (mAb MG-12B8), TK (mAb CS-4A5), gN (mAb
MuHV-4 ORF75
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has less need for long-distance intracellular capsid transport. In the
only cell types examined to date - fibroblasts [28], epithelial cells
[46] and dendritic cells [36] - infection occurs via endocytosis, and
capsids are released from late endosomes close to the nuclear
margin. Nevertheless, capsid transport over a short distance may
still be an important tegument function. The most direct
explanation for the ORF75c
2 phenotype would therefore be that
ORF75c links the viral capsid to host motor proteins for transport
to nuclear pores. ORF75c could then be released to enter the
nucleus and carry out its second function of PML body disruption.
A second possibility is that the role of ORF75c in capsid
transport is indirect. For example, ORF75c could recruit other
proteins into the tegument or be required for an orderly release of
tegument proteins after membrane fusion. A third possibility is
that capsid transport occurs by default, and poor transport reflects
Figure 8. ORF75c disruption impairs host colonization. A. Mice were infected intranasally (10
6 genomes each, equivalent to 10
3 p.f.u. for the
wild-type) with ORF75
+ (wild-type, revertant.1) or ORF75
2 (ORF75c
2.4, ORF75c
2.7) viruses. Lungs were collected 1 or 3 days later and spleens 30 days
later. Viral genome loads in 100 ng DNA from each sample was measured by real-time PCR of the M2 locus. Part of the adenosine phosphoribosyl
transferasegene was amplified as a cellular control. Each bar shows mean and SEM values for groups of 5 mice. B. Mice were infected intranasally (10
6
genomes each) with wild-type or ORF75c
2.4 viruses. B cell activation in mediastinal lymph nodes was assayed after 6 d by flow cytometry of the
CD69 activation marker on CD19
+ B cells. Equivalent B cells from naive mice are typically 5%CD69
+. After 30 d, virus-driven CD8
+Vb4
+ T cell expansion
was measured by flow cytometry of spleen cells. Typically 5% of CD8
+ splenic T cells are Vb4
+ in uninfected mice. Each bar shows mean and SEM
values for 5 individual mice. C. Mice were infected as in A, then analyzed 30 days later for MuHV-4-specific serum IgG by ELISA.
doi:10.1371/journal.pone.0002781.g008
3F7) or gB (mAb MG-4D11). Nuclei were counterstained with DAPI (blue). C. BHK-21 cells were infected (1000 genomes/cell, 6 h) with ORF75c+ (wild
type, revertant.1 or revertant.2) or ORF75c
2 (ORF75c
2.4, ORF75c
2.7, ORF75c
2.9) MuHV-4, then stained for ORF65 or gB as in B. D. NIH-3T3 cells were
infected (1000 genomes/cell) with wild-type or ORF75
2.4 MuHV-4 for 1, 2 or 6 h. The cells were then fixed, permeabilized and co-stained for ORF25
(BH-6D3, IgG1, red) and gN (3F7, IgG2a, green), or for ORF65 (MG-12B8, IgG2a, red) and gp70 (T3B8, IgG1, green), using isotype-specific detection.
Nuclei were counterstained with DAPI (blue).
doi:10.1371/journal.pone.0002781.g007
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ORF75c. This was suggested by ORF75c affecting PML, since
PML is one of a large family of structurally related tripartite motif
(TRIM) proteins, at least some of which participate in anti-viral
defence [47]. TRIM functions are largely undefined, but TRIM1
and TRIM5a are known to target incoming retroviruses before
nuclear entry. Herpesviruses are equally ancient pathogens, so
important interactions with TRIMs would not be a surprise. If
ORF75c can interact with one TRIM it could potentially interact
with others too, and if ORF75c can interact, so might ORFs 75a
and 75b. The multiplicity and diversity of host TRIMs would then
provide an explanation for the duplication and diversity of
gamma-herpesvirus FGARAT homologues.
In summary, the evolution of a captured host FGARAT into a
set of viral tegument proteins had suggested that these proteins no
longer function mainly as FGARATs, and such was found to be
the case. ORF75c showed functional similarity to the EBV
BNRF1, in that infection by the knockout virus was inhibited at a
pre-nuclear entry step. ORFs 75a and 75b, although related in
DNA sequence to ORF75c and also present in the tegument, were
unable to substitute for it, indicating that their functions are
distinct. The molecular explanation for the ORF75c
2 phenotype
of defective incoming capsid transport remains incomplete.
However, the effect of ORF75c on PML (TRIM19), while
insufficient by itself to explain the low infectivity of ORF75c
2
mutants, suggested that ORF75c might also target other TRIMs.
Innate anti-viral defences are plausible targets for the herpesvirus
tegument, as incoming genomes must reach the nucleus silently
enough for latently infected cells not to become immune targets.
Mapping the ORF75 host interaction partners may tell us how this
is achieved.
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